[ad_1] Three months after the second dose (administered 28 days after the first), participants in Moderna’s covid-19 vaccine study demonstrated high levels of antibodies. “This suggests that the vaccine will provide lasting immunity,” the lead researcher said. A new study recently published in The New England Journal of Medicine suggests …
Read More »
[ad_1] The first brick of the national vaccination strategy has been laid. On Monday, the High Authority for Health (HAS), an independent body of the executive, issued its recommendations on priority populations for accessing Covid-19 vaccines. IS “probably” early 2021. A plan drawn up blindly, due to the lack of …
Read More »
[ad_1] The American company Moderna announced that the full results of the latest clinical study confirmed a 94.1% efficacy of its COVID-19 vaccine and will require emergency clearance from both the Food and Drug Administration (FDA) in The United States, as well as the European Medicines Agency (EMA), inform Agepres. …
Read More »
[ad_1] Vaccination against the SARS-CoV-2 virus could begin in European Union countries in the first quarter of next year, says Andrea Ammon, head of the European Center for Disease Prevention and Control (ECDC), reports Euronews. Read also: A nightmare winter awaits us: Romanian agriculture has collapsed and production is at …
Read More »
[ad_1] JN / Agencies Today at 16:05 The European Medicines Agency (EMA) hopes to give a favorable opinion on a first vaccine against the new coronavirus “by the end of the year” which will be distributed “from January,” its director, Guido Rasi said Saturday. “If the data is solid, we …
Read More »
[ad_1] The European Medicines Agency has announced that it has initiated an ongoing evaluation procedure for the Pfizer BioNTech vaccine, so that when the final results of the third test phase are ready, it can introduce it into an accelerated approval process. BioNTech chief Ugur Shahin predicts that the time …
Read More »